Changing mechanisms of opiate tolerance and withdrawal during early development: Animal models of the human experience

ILAR Journal

Volumn 52, Issue 3, 2011, Pages 329-341

  Barr, Gordon A ^a,b   McPhie Lalmansingh, Anika ^c   Perez, Jessica ^e   Riley, Michelle ^d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MANILA Consulting Group in McLean   (United States)

^d MERCY COLLEGE   (United States)

^e NONE

Author keywords

Dependence; Glutamate; Infant; Morphine; Opi ate; Protein kinase; Rodent model; Tolerance; Withdrawal

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ANIMAL; ANIMAL MODEL; BRAIN; HUMAN; OPIATE ADDICTION; PAIN;

ANALGESICS, OPIOID; ANIMALS; BRAIN; HUMANS; MODELS, ANIMAL; OPIOID-RELATED DISORDERS; PAIN;

EID: 84873452596     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar.52.3.329     Document Type: Article

References (123)

1. Anand KJ, Willson DF, Berger J, Harrison R, Meert KL, Zimmerman J, Carcillo J, Newth CJ, Prodhan P, Dean JM, Nicholson C. 2010. Toler-ance and withdrawal from prolonged opioid use in critically ill children. Pediatrics 125:e1208-e1225.
2. Bannister K, Dickenson AH. 2009. Opioid hyperalgesia. Curr Opin Support Palliat Care 4:1-5.
3. Bardo MT, Hughes RA. 1981. Single-dose tolerance to morphine-induced analgesic and hypoactive effects in infant rats. Dev Psychobiol 14:415-423.
4. Barr GA, Goodwin GA. 1997. Precipitated morphine withdrawal induces a conditioned aversion in the preweaning rat. Pharmacol Biochem Behav 57:779-783.
5. Barr GA, Wang S. 1992. Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup. Eur J Pharmacol 215:35-42.
6. Barr GA, Paredes W, Erickson KL, Zukin RS. 1986. Kappa opioid receptor-mediated analgesia in the developing rat. Brain Res 394:145-152.
7. Barr GA, Wang S, Carden S. 1994. Aversive properties of the k opioid ago-nist U50,488 in the week-old rat pup. Psychopharmacol 113:422-428.
8. Barr GA, Zmitrovich A, Hamowy AS, Liu PY, Wang S, Hutchings DE. 1998. Neonatal withdrawal following pre-and postnatal exposure to methadone in the rat. Pharmacol Biochem Behav 60:97-104.
9. Bekhit MH. 2010. Opioid-induced hyperalgesia and tolerance. Am J Ther 17:498-510.
10. Bell JA, Beglan CL. 1995a. Co-treatment with MK-801 potentiates nalox-one-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat. Eur J Pharmacol 294:297-301.
11. Bell JA, Beglan CL. 1995b. MK-801 blocks the expression but not the de-velopment of tolerance to morphine in the isolated spinal cord of the neonatal rat. Eur J Pharmacol 294:289-296.
12. Ceger P, Kuhn CM. 2000. Opiate withdrawal in the neonatal rat: Relation-ship to duration of treatment and naloxone dose. Psychopharmacology (Berl) 150:253-259.
13. Chen Y, Sommer C. 2009. The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol 40:101-107.
14. Chieng B, Keay KA, Christie MJ. 1995. Increased fos-like immunoreactiv-ity in the periaqueductal gray of anaesthetised rats during opiate with-drawal. Neurosci Lett 183:79-82.
15. Choe CH, Smith FL. 2000. Sedative tolerance accompanies tolerance to the analgesic effects of fentanyl in infant rats. Pediatr Res 47:727-735.
16. Clancy B, Kersh B, Hyde J, Darlington RB, Anand KJ, Finlay BL. 2007. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 5:79-94.
17. Coghlan D, Milner M, Clarke T, Lambert I, McDermott C, McNally M, Beckett M, Matthews T. 1999. Neonatal abstinence syndrome. Ir Med J 92:232-233, 236.
18. Crain SM, Shen K. 2000. Enhanced analgesic potency and reduced toler-ance of morphine in 129/SvEv mice: Evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions. Brain Res 856:227-235.
19. De Vries TJ, Hogenboom F, Mulder AH, Schoffelmeer ANM. 1990. Ontog-eny of mu-, delta-and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. Dev Brain Res 54:63-69.
20. DeCasper AJ, Fifer WP. 1980. Of human bonding: Newborns prefer their mothers' voices. Science 208:1174-1176.
21. Dobbing J. 1981. Later development of the brain and its vulnerability. In: Davis JA, Dobbing J, eds. Scientific Foundations of Paediatrics. London: William Heinemann. p 744-759.
22. Druhan JP, Walters CL, Aston-Jones G. 2000. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal. J Pharma-col Exp Ther 294:531-538.
23. Dumas EO, Pollack GM. 2008. Opioid tolerance development: A pharma-cokinetic/pharmacodynamic perspective. AAPS J 10:537-551.
24. Eaton DG, Wertheim D, Oozeer R, Royston P, Dubowitz L, Dubowitz V. 1992. The effect of pethidine on the neonatal EEG. Dev Med Child Neu-rol 34:155-163.
25. Elliott K, Kest B, Man A, Kao B, Inturrisi CE. 1995. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology 13:347-356.
26. Fendt M, Mucha RF. 2001. Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states. Psychopharmacology (Berl) 155:242-250.
27. Franck L, Vilardi J. 1995. Assessment and management of opioid with-drawal in ill neonates. Neonatal Netw 14:39-48.
28. Franck LS, Harris SK, Soetenga DJ, Amling JK, Curley MA. 2008. The Withdrawal Assessment Tool-1 (WAT-1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediat-ric patients. Pediatr Crit Care Med 9:573-580.
29. Frenois F, Le Moine C, Cador M. 2005a. The motivational component of withdrawal in opiate addiction: Role of associative learning and aver-sive memory in opiate addiction from a behavioral, anatomical and functional perspective. Rev Neurosci 16:255-276.
30. Frenois F, Stinus L, Di Blasi F, Cador M, Le Moine C. 2005b. A specific limbic circuit underlies opiate withdrawal memories. J Neurosci 25:1366-1374.
31. Gewolb IH, Fishman D, Qureshi MA, Vice FL. 2004. Coordination of suck-swallow-respiration in infants born to mothers with drug-abuse prob-lems. Dev Med Child Neurol 46:700-705.
32. Handelsman L, Aronson MJ, Ness R, Cochrane KJ, Kanof PD. 1992. The dysphoria of heroin addiction. Am J Drug Alcohol Abuse 18:275-287.
33. Happel J. 1892. Morphinism in its relation to the sexual functions and ap-petite and its effect on the off-spring of the users of the drug. Med Surg Rep 68:403-407.
34. Huidobro JP, Huidobro F. 1973. Acute morphine tolerance in new born and young rats. Psychopharmacologia 28:27-34.
35. Hutchings DE. 1990. Issues of risk assessment: Lessons from the use and abuse of drugs during pregnancy. Neurotoxicol Teratol 12:183-189.
36. Hutchings DE, Feraur E, Gorinson HS, Golden R. 1979. The effects of pre-natal exposure to methadone on the rest-activity cycle of the prewean-ling rat. Neurobehav Toxicol Teratol 1:33-40.
37. Hutchings DE, Towey JP, Bodnarenko SR. 1980. Effects of prenatal metha-done on activity level in the preweanling rat. Neurotoxicol Teratol 2:231-235.
38. Inturrisi CE. 1997. Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence. Sem Neurosci 9:110-119.
39. Jones KL, Barr GA. 1995. Ontogeny of morphine withdrawal in the rat. Behav Neurosci 109:1189-1198.
40. Jones KL, Barr GA. 2000. Opiate withdrawal in the fetal rat: A behavioral profile. Pharmacol Biochem Behav 66:419-424.
41. Jones KL, Barr GA. 2001. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala pre-cipitates morphine withdrawal in the 7 day-old rat. Synapse 39:139-151.
42. Jones KL, Zhu H, Jenab S, Du T, Inturrisi CE, Barr GA. 2002. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology 26:301-310.
43. Kanof PD, Aronson MJ, Ness R. 1993. Organic mood syndrome associated with detoxification from methadone maintenance. Am J Psychiatry 150:423-428.
44. Keegan J, Parva M, Finnegan M, Gerson A, Belden M. 2010. Addiction in pregnancy. J Addict Dis 29:175-191.
45. Kest B, Hopkins E, Palmese CA, Adler M, Mogil JS. 2002. Genetic varia-tion in morphine analgesic tolerance: A survey of 11 inbred mouse strains. Pharmacol Biochem Behav 73:821-828.
46. King TE, Barr GA. 2003. Functional development of neurokinin peptides substance P and neurokinin A in nociception. Neuroreport 14:1603-1607.
47. King TE, Cheng J, Wang S, Barr GA. 2000a. Maturation of NK1 receptor involvement in the nociceptive response to formalin. Synapse 36:254-266.
48. King TE, Heath MJ, Debs P, Davis MB, Hen R, Barr GA. 2000b. The devel-opment of the nociceptive responses in neurokinin-1 receptor knockout mice. Neuroreport 11:587-591.
49. King T, Gardell LR, Wang R, Vardanyan A, Ossipov MH, Malan TP, Van-derah TW, Hunt SP, Hruby VJ, Lai J, Porreca F. 2005. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 116:276-288.
50. Kirby ML. 1981. Effects of morphine and naloxone on spontaneous activity of fetal rats. Exp Neurol 73:430-439.
51. Kolesnikov Y, Jain S, Wilson R, Pasternak GW. 1998. Lack of morphine and enkephalin tolerance in 129/SvEv mice: Evidence for a NMDA receptor defect. J Pharmacol Exp Ther 284:455-459.
52. Koob GF, Wall TL, Bloom FE. 1989. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacol 98:530-534.
53. Kuschel CA, Austerberry L, Cornwell M, Couch R, Rowley RS. 2004. Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome? Arch Dis Child Fetal Neonatal Ed 89:F390-F393.
54. Leslie FM, Loughlin SE. 1993. Ontogeny and plasticity of opioid systems. In: Hammer RP, ed. The Neurobiology of Opiates. Boca Raton: CRC Press. p 85-123.
55. Leslie FM, Tso S, Hurlbut DE. 1982. Differential appearance of opiate re-ceptor subtypes in neonatal rat brain. Life Sci 31:1393-1396.
56. Lester BM, Lagasse LL. 2010. Children of addicted women. J Addict Dis 29:259-276.
57. Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, Bada HS, Walls HH, Huestis MA, Finnegan LP, Maza PL. 2001. The Maternal Lifestyle Study: Drug use by meconium toxicology and maternal self-report. Pediatrics 107:309-317.
58. Liang DY, Guo T, Liao G, Kingery WS, Peltz G, Clark JD. 2006. Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain 121:232-240.
59. Maeda T, Kishioka S, Inoue N, Shimizu N, Fukazawa Y, Ozaki M, Yamamoto H. 2002. Naloxone-precipitated morphine withdrawal elicits in-creases in c-Fos mRNA expression in restricted regions of the infant rat brain. Jpn J Pharmacol 90:270-275.
60. Maldonado R, Stinus L, Gold LH, Koob GF. 1992. Role of different brain structures in the expression of the physical morphine withdrawal syn-drome. J Pharmacol Exper Ther 261:669-677.
61. Mao J. 1999. NMDA and opioid receptors: their interactions in antinocicep-tion, tolerance and neuroplasticity. Brain Res Brain Res Rev 30:289-304.
62. McClung CA. 2006. The molecular mechanisms of morphine addiction. Rev Neurosci 17:393-402.
63. McKelvy AD, Sweitzer SM. 2008. Endothelin-1 exposure on postnatal day 7 alters expression of the endothelin B receptor and behavioral sensitiv-ity to endothelin-1 on postnatal day 11. Neurosci Lett 451:89-93.
64. McKelvy AD, Sweitzer SM. 2009. Decreased opioid analgesia in weanling rats exposed to endothelin-1 during infancy. Neurosci Lett 466:144-148.
65. McKelvy AD, Mark TR, Sweitzer SM. 2007. Age-and sex-specific nocicep-tive response to endothelin-1. J Pain 8:657-666.
66. McPhie AA, Barr GA. 2000. The role of opioid receptors in morphine with-drawal in the infant rat. Dev Brain Res 124:73-80.
67. McPhie AA, Barr GA. 2009. Regional Fos expression induced by morphine withdrawal in the 7-day-old rat. Dev Psychobiol 51:544-552.
68. Moon CM, Fifer WP. 2000. Evidence of transnatal auditory learning. J Perinatol 20(8 Pt 2):S37-S44.
69. Mucha RF, Gritti MD, Kim C. 1986. Aversive properties of opiate with-drawal studied in rats. NIDA Res Monogr 75:567-570.
70. Myers MM, Shair HN, Hofer MA. 1992. Feeding in infancy: Short-and long-term effects on cardiovascular function. Experientia 48:322-333.
71. Nestler EJ, Hope BT, Widnell KL. 1993. Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11:995-1006.
72. Noda Y, Nabeshima T. 2004. Opiate physical dependence and N-methyl-D-aspartate receptors. Eur J Pharmacol 500:121-128.
73. O'Brien CM, Jeffery HE. 2002. Sleep deprivation, disorganization and frag-mentation during opiate withdrawal in newborns. J Paediatr Child Health 38:66-71.
74. Osborn DA, Jeffery HE, Cole MJ. 2010a. Opiate treatment for opiate with-drawal in newborn infants. Cochrane Database Syst Rev:CD002059.
75. Osborn DA, Jeffery HE, Cole MJ. 2010b. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev:CD002053.
76. Perez-Saad H, Urba-Holmgren R, Holmgren B. 1996. Pharmacological analysis of acute morphine dependence in infant rats: Close molecular relationship of head-shaking precipitated by opiate antagonists and cho-linergic neurotransmission. Arch Med Res 27:139-144.
77. Quigley KS, Shair HN, Myers MM. 1996. Parasympathetic control of heart period during early postnatal development in the rat. J Auton Nerv System 59:75-82.
78. Raehal KM, Bohn LM. 2005. Mu opioid receptor regulation and opiate re-sponsiveness. AAPS J 7:E587-E591.
79. Richardson KA, Yohay AL, Gauda EB, McLemore GL. 2006. Neonatal animal models of opiate withdrawal. ILAR J 47:39-48.
80. Schempf AH. 2007. Illicit drug use and neonatal outcomes: A critical re-view. Obstet Gynecol Surv 62:749-757.
81. Shahak H, Slotkin TA, Yanai J. 2003. Alterations in PKCgamma in the mouse hippocampus after prenatal exposure to heroin: A link from cell signaling to behavioral outcome. Brain Res Dev Brain Res 140:117-125.
82. Shannon LM, Havens JR, Hays L. 2010. Examining differences in substance use among rural and urban pregnant women. Am J Addict 19:467-473.
83. Shute E, Davis ME. 1933. The effect on the infant of morphine adminis-tered in labor. Surg Gynecol Obstet 57:727-736.
84. Smotherman WP. 2002. Classical conditioning in the rat fetus: Involvement of mu and kappa opioid systems in the conditioned response. Dev Psy-chobiol 40:104-115.
85. Spain JW, Roth BL, Coscia CJ. 1985. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa). J Neurosci 5:584-588.
86. Stickrod G, Kimble DP, Smotherman WP. 1982. In utero taste/odor aversion conditioning in the rat. Pharmacol Biochem Behav 28:5-7.
87. Stoller DC, Thornton SR, Smith FL. 2002. Loss of antinociceptive efficacy in rat pups infused with morphine from osmotic minipumps. Pharma-cology 66:11-18.
88. Stoller DC, Sim-Selley LJ, Smith FL. 2007. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats. Brain Res 1142:28-36.
89. Sullivan RM, Moriceau S, Raineki C, Roth TL. 2009. Ontogeny of infant fear learning and the amygdala. In: Gazzaniga M, ed. Cognitive Neuro-science IV. Cambridge MA: MIT Press. p 889-904.
90. Sweitzer SM, Shumilla JA, Zisson MH, Kendig JJ. 2003. Protein kinase C epsilon and gamma: Roles in age-specific modulation of acute opioid-withdrawal allodynia. Sem Pain Med 1:206-219.
91. Sweitzer SM, Allen CP, Zissen MH, Kendig JJ. 2004a. Mechanical allo-dynia and thermal hyperalgesia upon acute opioid withdrawal in the neonatal rat. Pain 110:269-280.
92. Sweitzer SM, Wong SM, Tjolsen A, Allen CP, Mochly-Rosen D, Kendig JJ. 2004b. Exaggerated nociceptive responses on morphine withdrawal: Roles of protein kinase C epsilon and gamma. Pain 110:281-289.
93. Szeto HH, Zhu YS, Amione J, Clare S. 1988. Prenatal morphine exposure and sleep-wake disturbances in the fetus. Sleep 11:121-130.
94. Szeto HH, Zhu Y-S, Cai L-Q. 1990. Central opioid modulation of fetal car-diovascular function: Role of mu-and delta-receptors. Am J Physiol Regul Integr Comp Physiol 258:R1453-R1458.
95. Tate MA. 1899. The transmissibility of morphine. Cincinnati Lancet-Clinic 43:598-603.
96. Tempel A. 1991. Visualization of mu opiate receptor downregulation fol-lowing morphine treatment in neonatal rat brain. Brain Res Dev Brain Res 64:19-26.
97. Tempel A, Habas J, Paredes W, Barr GA. 1988. Morphine-induced down-regulation of mu-opioid receptors in neonatal rat brain. Brain Res 469:129-133.
98. Thomson LM, Zeng J, Terman GW. 2006. Differential effect of glutamate transporter inhibition on EPSCs in the morphine naive and morphine tolerant neonatal spinal cord slice. Neurosci Lett 407:64-69.
99. Thomson LM, Terman GW, Zeng J, Lowe J, Chavkin C, Hermes SM, He-garty DM, Aicher SA. 2008. Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of mor-phine-treated neonatal rats. J Pain 9:11-19.
100. Thorat SN, Barjavel MJ, Matwyshyn GA, Bhargava HN. 1994. Compara-tive effects of NG-monomethyl-L-arginine and MK-801 on the absti-nence syndrome in morphine-dependent mice. Brain Res 642:153-159.
101. Thornton SR, Smith FL. 1997. Characterization of neonatal rat fentanyl tol-erance and dependence. J Pharmacol Exp Ther 281:514-521.
102. Thornton SR, Wang AF, Smith FL. 1997. Characterization of neonatal rat morphine tolerance and dependence. Eur J Pharmacol 340:161-167.
103. Trujillo KA. 1995. Effects of noncompetitive N-methyl-D-aspartate recep-tor antagonists on opiate tolerance and physical dependence. Neuropsy-chopharmacology 13:301-307.
104. Trujillo KA. 2000. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychophar-macology (Berl) 151:121-141.
105. van Praag H, Frenk H. 1991. Evidence for opiate tolerance in newborn rats. Dev Brain Res 60:99-102.
106. van Praag H, Falcon M, Guendelman D, Frenk H. 1993. The development of analgesic, pro-and anti-convulsant opiate effects in the rat. Ann Ist Super Sanita 29:419-429.
107. Vathy I. 2002. Prenatal opiate exposure: Long-term CNS consequences in the stress system of the offspring. Psychoneuroendocrinology 27:273-283.
108. Vaupel DB, Kimes AS, London ED. 1995a. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid with-drawal. Psychopharmacol (Berl) 118:361-368.
109. Vaupel DB, Kimes AS, London ED. 1995b. Nitric oxide synthase inhibi-tors: Preclinical studies of potential use for treatment of opioid with-drawal. Neuropsychopharmacology 13:315-322.
110. Windh RT, Little PJ, Kuhn CM. 1995. The ontogeny of mu opiate tolerance and dependence in the rat: Antinociceptive and biochemical studies. J Pharmacol Exper Ther 273:1361-1374.
111. Yanagisawa M, Murakoshi T, Tamai S, Otsuka M. 1984. Tail-pinch method in vitro and effects of some antinociceptive compounds. Eur J Pharma-col 106:231-239.
112. Yanai J, Huleihel R, Izrael M, Metsuyanim S, Shahak H, Vatury O, Yaniv SP. 2003. Functional changes after prenatal opiate exposure related to opiate receptors' regulated alterations in cholinergic innervation. Int J Neuropsychopharmacol 6:253-265.
113. Yaniv SP, Naor Z, Yanai J. 2004. Prenatal heroin exposure alters cholinergic receptor stimulated activation of the PKCbetaII and PKCgamma iso-forms. Brain Res Bull 63:339-349.
114. Zeng J, Thomson LM, Aicher SA, Terman GW. 2006. Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tol-erance in neonatal rats. J Neurosci 26:12033-12042.
115. Zhai H, Li Y, Wang X, Lu L. 2008. Drug-induced alterations in the extracel-lular signal-regulated kinase (ERK) signalling pathway: Implications for reinforcement and reinstatement. Cell Mol Neurobiol 28:157-172.
116. Zhang GH, Sweitzer SM. 2008. Neonatal morphine enhances nociception and decreases analgesia in young rats. Brain Res 1199:82-90.
117. Zhang Y, Xiong W, Lin X, Ma X, Yu LC. 2009. Receptor trafficking induced by mu-opioid-receptor phosphorylation. Neurosci Biobehav Rev 33:1192-1197.
118. Zhu H, Barr GA. 2000. Naltrexone-precipitated morphine withdrawal in in-fant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists. Psychopharmacology (Berl) 150:325-336.
119. Zhu H, Barr GA. 2001. Opiate withdrawal during development: Are NMDA receptors indispensable? Trends Pharmacol Sci 22:404-408.
120. Zhu H, Barr GA. 2003. Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat. Pain 104:437-447.
121. Zhu H, Barr GA. 2004. The role of AMPA and metabotropic glutamate re-ceptors on morphine withdrawal in infant rats. Int J Dev Neurosci 22:379-395.
122. Zissen MH, Zhang G, Kendig JJ, Sweitzer SM. 2006. Acute and chronic mor-phine alters formalin pain in neonatal rats. Neurosci Lett 400:154-157.
123. Zissen MH, Zhang G, McKelvy A, Propst JT, Kendig JJ, Sweitzer SM. 2007. Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats. Neuroscience 144:247-262.